Radio and PodcastLive Radio & Podcasts

Search Radio and Podcast

Podcasts›Oncotarget›Oncotarget Supports WIN 2026 Symposium Advancing Precision Oncology

Science & Medicine

Oncotarget Supports WIN 2026 Symposium Advancing Precision Oncology

Oncotarget by Oncotarget Podcast

Sep 8, 202600:02:33Science & Medicine

BUFFALO, NY - September 8, 2026 – Oncotarget is proud to support the WIN 2026 Symposium, organized by the Worldwide Innovative Networking (WIN) Consortium, taking place October 2–3, 2026, at the Rhode Island Convention C...

Related Episodes

Continue listening to more episodes from Oncotarget.

Molecular Tumor Board Maps Precision Treatment Options for a Woman With Multiple Primary Cancers

Oct 20, 2026 - 00:17:02

When one person develops several cancers over the course of many years, treatment decisions can become in...

Pan-Cancer Analysis Identifies Buckwheat-Derived Compound as Potential AKT1 Drug-Design Candidate

Oct 14, 2026 - 00:08:26

BUFFALO, NY – October 14, 2026 – A new paper was in Volume 17 of on October 12, 2026, titled “Integrative...

Epigenetic Silencing of TRAIL-R2 Is Linked to Aggressive Features in Breast Cancer

Oct 6, 2026 - 00:14:04

Cancer cells often survive by disrupting the molecular pathways that normally eliminate damaged or abnorm...

Gut Microbiome Emerges as a Potential Partner in Precision Cancer Therapy

Sep 28, 2026 - 00:06:09

BUFFALO, NY – September 28, 2026 – A new was in Volume 17 of Oncotarget on September 23, 2026, titled “Gu...

DHHC3 Helps Melanoma Tumors Evade Antitumor Immunity

Sep 23, 2026 - 00:11:16

Cancer cells do not grow in isolation. Their ability to survive and form tumors depends partly on how the...

Commentary Calls for Consistent Evaluation of Potential Links Between COVID-19, Vaccination and Cancer

Sep 17, 2026 - 00:02:02

BUFFALO, NY – September 17, 2026 – A new was in Volume 17 of Oncotarget on September 11, 2026, titled “Ar...

Restoring MHC-I Expression Could Strengthen Immune Responses Against CNS Cancers

Sep 9, 2026 - 00:06:42

BUFFALO, NY – September 9, 2026 – A new was in Volume 17 of Oncotarget on September 8, 2026, titled “Re-e...

Therapeutic HPV Vaccine PepCan Tested for Preventing Head and Neck Cancer Recurrence

Sep 8, 2026 - 00:12:46

Head and neck squamous cell carcinoma (HNSCC) can return even after patients complete surgery, radiation,...